Description |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Himmel Pharma |
|
Product Type |
Product Size |
Product Company |
Injection |
1'S |
AJM Pharmaceuticals |
|
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Himmel Pharma |
|
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Sandoz |
|
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Pfizer |
Amlodipine besylate 5mg
|
Product Type |
Product Size |
Tablet |
20'S |
Product Company |
Mass Pharma |
Amlodipine 5mg
|
Content | Etrombopag olamine product ingredient for etrombopag. It is used to treat low blood platelet counts in adults with chronic immune , thrombocytopenia or aplastic anemia. | Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. | Gemcitabine is a cytidine analog with two fluorine atoms.As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells. | Paclitaxel is a taxoid chemotherapeutic agent used as first line and subsequently therapy for treatment of advanced carcinoma of the ovary and other cancers, including breast and lung cancer . PTX binds to microtublues instead of tubulin dimers and stabilizes microtubules by promoting the assembly of alpha and beta tubulin subunits,the building blocks of microtubules. | Amlodipine is an oral antihypertensive medicine that belongs to the class of calcium channel blockers. It works by relaxing the blood vessels to allow easy flow of blood
| Amlodipine is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. It controls chest pain by increasing the supply of blood to the heart
|
Reviews
There are no reviews yet.